

Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
CTLT | NYSE | USD | Real-time | |
0C8 | Frankfurt | EUR | Delayed | |
CTLT-RM | Moscow | RUB | Real-time |
Catalent (NYSE:CTLT) was cut to Neutral from Overweight with a $45 price target, down from $90 per share by JPMorgan analysts on Friday. They told investors that operational fixes are in sight, but...
Here is your Pro Recap of the biggest analyst cuts you may have missed today: downgrades for Nike, Foot Locker, Canadian National Railway, and Catalent.InvestingPro subscribers got these headlines in...
Shares of drug manufacturer Catalent (NYSE:CTLT) declined Friday morning after telling investors it will provide a business update today instead of a normal review of its third-quarter results. This...
Catalent (CTLT) Sees FY23 Revenue of $4.25B to $4.35B vs Consensus $4.44B (Prior $4.625B -$4.875B)Adjust EBITDA $725M to $775MAdj. Net Income $187M to $228M
By Bhanvi Satija and Pratik Jain (Reuters) -Contract drug manufacturer Catalent (NYSE:CTLT) Inc on Friday slashed its full-year forecasts for profit and sales and delayed its quarterly results for...
Investing.com -- Stocks in focus in premarket trade on Friday, May 19th. Please refresh for updates. Foot Locker (NYSE:FL) stock slumped 25% after the footwear retailer reported...
BofA analysts downgraded Catalent (NYSE:CTLT) to Underperform from Neutral, cutting the firm's price target on the stock to $28 from $49 per share in a note. The analysts told investors that the firm...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review